Cargando…
Chimeric antigen receptors that trigger phagocytosis
Chimeric antigen receptors (CARs) are synthetic receptors that reprogram T cells to kill cancer. The success of CAR-T cell therapies highlights the promise of programmed immunity and suggests that applying CAR strategies to other immune cell lineages may be beneficial. Here, we engineered a family o...
Autores principales: | Morrissey, Meghan A, Williamson, Adam P, Steinbach, Adriana M, Roberts, Edward W, Kern, Nadja, Headley, Mark B, Vale, Ronald D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008046/ https://www.ncbi.nlm.nih.gov/pubmed/29862966 http://dx.doi.org/10.7554/eLife.36688 |
Ejemplares similares
-
Tight nanoscale clustering of Fcγ receptors using DNA origami promotes phagocytosis
por: Kern, Nadja, et al.
Publicado: (2021) -
Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12
por: Chi, Xiaowei, et al.
Publicado: (2019) -
Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme
por: Marei, Hany E., et al.
Publicado: (2021) -
Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors
por: Burton, Jake, et al.
Publicado: (2023) -
Dynamics of human protein kinase Aurora A linked to drug selectivity
por: Pitsawong, Warintra, et al.
Publicado: (2018)